KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Liabilities and Shareholders Equity (2016 - 2025)

Abbott Laboratories (ABT) has disclosed Liabilities and Shareholders Equity for 17 consecutive years, with $86.7 billion as the latest value for Q4 2025.

  • Quarterly Liabilities and Shareholders Equity rose 6.51% to $86.7 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $336.3 billion through Dec 2025, up 11.65% year-over-year, with the annual reading at $86.7 billion for FY2025, 6.51% up from the prior year.
  • Liabilities and Shareholders Equity hit $86.7 billion in Q4 2025 for Abbott Laboratories, up from $84.2 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $86.7 billion in Q4 2025 to a low of $2.9 billion in Q4 2022.
  • Historically, Liabilities and Shareholders Equity has averaged $69.1 billion across 5 years, with a median of $73.6 billion in 2023.
  • Biggest five-year swings in Liabilities and Shareholders Equity: plummeted 62.55% in 2022 and later soared 2439.51% in 2023.
  • Year by year, Liabilities and Shareholders Equity stood at $7.7 billion in 2021, then plummeted by 62.55% to $2.9 billion in 2022, then skyrocketed by 2439.51% to $73.2 billion in 2023, then increased by 11.2% to $81.4 billion in 2024, then increased by 6.51% to $86.7 billion in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for ABT at $86.7 billion in Q4 2025, $84.2 billion in Q3 2025, and $84.0 billion in Q2 2025.